Skip to main content
Caplight Logo









Lucis

Lucis

Private
ParisHealthcare & Life Scienceshttps://www.lucis.life/

Last Round

Series A

May 26, 2026

Est. Valuation

$1.79M

Total Funding Raised

$29M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Lucis is a European preventative health-tech company that provides an AI-powered platform to transform blood test results into personalized health insights and actionable recommendations.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Patient Engagement

Business Model

B2C

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

preventive health platformbiomarker trackingdigital healthteleconsultationhealth techlongevitypersonalized healthcontinuous glucose monitoringCGMhealth analyticspatient engagementbiohackingsubscription SaaSpreventive medicinehealth companion app

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lucis Comparables

Compare Lucis with similar companies based on industry and business-model similarity.

Lucis comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Zoï
80%
Qura
78%
Emerald
75%

Lucis Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 26, 2026
SeedDec 16, 2025
AcceleratorJun 9, 2025

Key People

Founding team and executive leadership

Baptiste Debever

Co-Founder CTO

Founding Team

Lucis Investors

Notable investors and investment history

Lucis investors
InvestorRounds
Kima VenturesSeed, Accelerator
LongGame VenturesAccelerator
Circle & CoSeed
SingularSeries A
General CatalystSeries A, Seed
Motier VenturesSeed
Y CombinatorSeed, Accelerator, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2026

    Open roles increased to 14, representing 50% of headcount.

  • Aug 17, 2026

    Open roles increased to 10, 3.5x the trailing average.

Recent news

Latest coverage and updates

  • has_revenueAug 20, 2026

    Lucis had revenue of $1.1M on Sep 1st '25.

Lucis Filings

Explore SEC and related filing metadata, where available.

Lucis filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Lucis's valuation, stock price, and market status.

Is Lucis a public or private company?

Lucis is a private company.

What is the current stock price of Lucis?

Lucis is a private company with no public stock price. No recent secondary market data is available.

How much is Lucis worth (valuation)?

Valuation information for Lucis is not publicly available.

Can I buy Lucis stock?

Lucis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Lucis's last funding round?

Lucis's most recent funding round was Series A on May 26, 2026.

Who are the main investors in Lucis?

Key investors in Lucis include Singular, General Catalyst.

Will Lucis IPO soon?

No public IPO plans have been announced for Lucis.

How can I track Lucis secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lucis's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParis
Employee Range28
Year Founded2025
Last FundingMay 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?